Skip to main content
ELVN logo

ELVN · Enliven Therapeutics, Inc. · Holdings

Track ELVN — free
$40.84 -0.14 (-0.34%)
Market Cap
$3.00B
Shares
73.27M
Volume · Oct 12 579.84K Avg daily vol (3M) 1.13M

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Some SEC filings for this period have not finished importing. Holder totals and changes may be incomplete; these filings remain queued for recovery.
The Sep 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out. Each fund's Change is measured against its own previous reported quarter, shown in the Reported column. Pick a completed quarter in the Quarter selector below to put every fund on one quarter and see the stock-wide activity breakdown.
Holders: 215
Total Value: $4,085,213,372
Total Shares: 80,497,126
Showing 1–100 of 219 holdings by value · page 1 of 3

Institutional Ownership Trend

15 quarters

Holder Concentration

Across 215 13F filers
Top Holder
12.5%
Sep 2023 → Jun 2026 · range 12.4% – 23.1%
of institutional value
Top 5
39.2%
Sep 2023 → Jun 2026 · range 39.2% – 64.6%
of institutional value
Top 10
55.1%
Sep 2023 → Jun 2026 · range 55.1% – 89.5%
of institutional value
HHI
436
Sep 2023 → Jun 2026 · range 436 – 1,134
Broadly held
Showing 100 of 219
Export CSV
Holder Value (USD) % of 13F Shares Open

Showing the top 100 of 219 holders. Create a free account to see every holder, past quarters, search, filters and CSV export.

Key facts CIK 1672619 CUSIP 29337E102 13F (30d) 5 filings 5 filers Visit website Investor relations